Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
J. Liu, P. Budylowski, R. Samson, B. D. Griffin, G. Babuadze, B. Rathod, K. Colwill, J. A. Abioye, J. A. Schwartz, R. Law, L. Yip, S. K. Ahn, S. Chau, M. Naghibosadat, Y. Arita, , M. A. Ostrowski
This paper evaluates a SARS-CoV-2 mRNA vaccine, PTX-COVID19-B, showing it is safe, effective, and induces strong immune responses in mice and hamsters, with ongoing human clinical trials.
bioRxiv · May 11, 2021Immunology